A modified competitive inhibition radioimunoassay for the detection of C3a use of 125I-C3 instead of 125I-C3a
- 1 April 1988
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 108 (1-2), 77-84
- https://doi.org/10.1016/0022-1759(88)90405-x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Biologically active complement (C5)-derived peptides and their relevance to diseaseCritical Reviews in Oncology/Hematology, 1984
- The Proteolytic Activation Systems of ComplementAnnual Review of Biochemistry, 1981
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.The Journal of Experimental Medicine, 1980
- ASSOCIATION OF COMPLEMENT ACTIVATION AND ELEVATED PLASMA-C5a WITH ADULT RESPIRATORY DISTRESS SYNDROMEThe Lancet, 1980
- Third component of human complement: structural analysis of the polypeptide chains of C3 and C3bBiochemistry, 1979
- Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.JCI Insight, 1977
- Third component of human complement: purification from plasma and physicochemical characterizationBiochemistry, 1976
- Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.JCI Insight, 1975
- Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific ActivityNature, 1962